Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,476.00    -14.00 (-0.94%)
Bid:
1,476.00
Ask:
1,480.00
Spread: 4.00 (0.271%)
Market Cap: £505.34m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

AGM Statement and Board Changes

21 Nov 2025 07:00

RNS Number : 4496I
Craneware plc
21 November 2025
 

Craneware plc

("Craneware" or the "Company")

 

AGM Statement and Board Changes

 

21 November 2025 - Craneware (AIM: CRW.L), a leader in healthcare financial performance solutions, provides an update on trading ahead of its Annual General Meeting, taking place at 10am today.

 

The Board is pleased to confirm that following the growth reported in FY25, the start of FY26 has seen the positive momentum continue. Alongside the Group's direct sales efforts, the alliance with Microsoft is progressing well, adding significant sales pipeline growth as well as continuing to help drive innovation. US healthcare providers remain focused on optimising their operational and financial performance, driving demand for the Group's solutions.

 

The Group continues to invest in R&D to strengthen its product set, leveraging its proprietary data assets to expand its offerings and launch new AI enabled applications. A recent area of focus has been the accelerated development of a product to support customers through the 340B drug rebate pilot program, whereby participating hospitals have to purchase an initial 9 named drugs at wholesale acquisition cost and later apply for manufacturer rebates. This program, announced on 30 October 2025 by the Health Resources and Services Administration ("HRSA"), is due to commence on 1 January 2026, creating further operational and administrative complexities for healthcare providers. As a result of prior investments in the Trisus platform, the depth of Craneware's data and its unique position of independence in the 340B vendor market, the Company has successfully brought this fully integrated solution to market in an accelerated timeframe, supporting its customers by reducing their financial risk, maintaining compliance and protecting resources for patient care. Having demonstrated the product through live meetings and a series of webinars, the solution is now being rolled out ahead of the deadline and is a testament to Craneware's leading position in the 340B market.

 

Board Changes

 

As previously announced, following many years of service on the Board of Directors, David Kemp, Senior Non-Executive Director, has decided not to stand for re-election at the Company's AGM later today and as a result, will retire from the Board following the close of the meeting. The Board thanks him for his significant contributions during his tenure. His insight and constructive challenge have been invaluable, helping drive Craneware's success.

 

Following the completion of the AGM, Alistair Erskine will assume the role of Senior Independent Director, Susan Nelson will assume the role of Chair of the Audit Committee and Jill Goldsmith will take over the role of Company Secretary to the Board.

 

Outlook

 

The strength of the Company's Annuity SaaS business model and balance sheet, its high levels of recurring revenue and strong cash generation provide Craneware with solid foundations as it executes on its growth strategy and the creation of long-term value for all stakeholders.

 

The Board remains confident in the delivery of continued growth over the near term, and the Group continues to trade in line with market expectations for the year.

 

For further information, please contact:

 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

Alma Strategic Communications

+44 (0)20 3405 0205

Caroline Forde, Kinvara Verdon, Sarah Peters

craneware@almastrategic.com

Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Neil Patel, Benjamin Cryer, Kate Bannatyne

Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Virginia Bull, Arnav Kapoor

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Patrick Dologhan

 

About Craneware

 

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider. The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve - today and in the future. Together, we are transforming the business of healthcare.

 

Learn more at www.thecranewaregroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFFFSILRLIFIE
Date   Source Headline
15th May 20268:36 amRNSNotification of Major Holdings
13th May 20266:11 pmRNSNotification of Major Holdings
13th May 20261:50 pmRNSNotification of Major Holdings
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
5th May 20265:11 pmRNSGrant of Share Options to Directors
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTransaction in Own Shares
27th Apr 202612:47 pmRNSNotification of Major Holdings
23rd Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSBlock Admission
13th Apr 202610:37 amRNSGrant of Share Option to PDMR
13th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 202611:26 amRNSDividend Currency Election
16th Mar 20267:00 amRNSShare buyback programme and Total Voting Rights
16th Mar 20267:00 amRNSShare buyback programme and Total Voting Rights
4th Mar 20267:00 amRNSDirector's Acquisition of Shares
2nd Mar 20267:00 amRNSFY26 Interim Results
18th Feb 20263:49 pmRNSNotification of Major Holdings
9th Feb 20264:55 pmRNSNotification of Major Holdings
3rd Feb 20263:16 pmRNSNotification of Major Holdings
20th Jan 20267:00 amRNSH1 FY26 Trading Update and Notice of Results
28th Nov 202511:31 amRNSDividend Currency Election
21st Nov 20251:51 pmRNSResult of AGM
21st Nov 20257:00 amRNSAGM Statement and Board Changes
20th Nov 20257:00 amRNSVesting of LTIP Awards and Total Voting Rights
13th Nov 202510:51 amRNSReduction of Capital effective
6th Nov 20253:41 pmRNSReduction of Capital confirmed
22nd Oct 20255:17 pmRNSAnnual Report, Notice of AGM, Directorate Change
22nd Oct 20259:24 amRNSTotal Voting Rights
15th Oct 20257:00 amRNSBlock listing Interim Review
17th Sep 20257:00 amRNSGrant of Long Term Incentive Plan Awards
15th Sep 20257:00 amRNSFY25 Final Results
1st Sep 20257:00 amRNSBank Refinancing
20th Aug 20256:22 pmRNSResult of General Meeting - Replacement
20th Aug 20254:28 pmRNSResult of AGM
1st Aug 20254:35 pmRNSProposed Reduction of Capital
16th Jul 20257:00 amRNSFY25 Trading Update
12th Jun 20253:20 pmRNSForm 8.3 - Craneware plc
12th Jun 202511:55 amRNSForm 8.5 (EPT/RI) - Craneware PLC
11th Jun 20253:00 pmRNSForm 8.3 - Craneware PLC
11th Jun 20252:47 pmRNSForm 8.3 - CRANEWARE PLC
11th Jun 20252:40 pmGNWForm 8.3 - Craneware Plc
11th Jun 202512:02 pmGNWForm 8.3 - [CRANEWARE PLC - 10 06 2025] - (CGWL)
11th Jun 202512:00 pmRNSForm 8.5 (EPT/RI) Craneware Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.